|
HS Code |
300870 |
| Chemical Name | D-Mannosamine Hydrochloride |
| Cas Number | 5505-63-1 |
| Molecular Formula | C6H15NO5·HCl |
| Molecular Weight | 217.65 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Melting Point | 170-172°C (dec.) |
| Storage Conditions | Store at 2-8°C, tightly closed |
| Purity | ≥98% |
| Synonyms | 2-Amino-2-deoxy-D-mannose hydrochloride |
| Ph 1 Solution | 4.0-6.0 |
As an accredited D-Mannosamine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | D-Mannosamine Hydrochloride, 5g, supplied in a sealed amber glass bottle with tamper-evident cap and clear labeling for safety. |
| Shipping | D-Mannosamine Hydrochloride is shipped in a tightly sealed container, protected from moisture and light. It is packed according to standard chemical safety regulations, with appropriate labeling and documentation. Shipping typically complies with local and international transport guidelines for laboratory chemicals, ensuring safe and secure delivery to the destination. |
| Storage | D-Mannosamine Hydrochloride should be stored in a tightly sealed container, protected from moisture and light, at a temperature of 2-8°C (refrigerated conditions). Ensure it is kept in a dry place, away from incompatible substances and sources of heat. Proper storage under these conditions maintains its stability and prevents contamination or degradation of the compound. |
Applications of D-Mannosamine Hydrochloride in Industrial ManufacturingD-Mannosamine Hydrochloride serves multiple specialized functions as an intermediate and active component in industrial sectors requiring precise formulation control, regulatory alignment, and reproducible scale-up. Below, our technical experts present exactly how downstream manufacturers integrate this raw material within critical application markets. 1. Glycosylation Pathway Reagent in Biopharmaceutical API SynthesisBioprocess manufacturers source D-Mannosamine Hydrochloride for targeted glycosylation pathway manipulation. The molecule acts as a hexosamine precursor to modify glycan branches in recombinant glycoprotein APIs, primarily for monoclonal antibodies and engineered glycoproteins. Downstream firms dose specific amounts in cell culture feeds or enzymatic coupling stages for increased sialylation, enhanced PK profiles, and improved biological activity, under stringent GMP oversight. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Substrate in Heparin and Heparan Sulfate Oligosaccharide SynthesisSpecialty carbohydrate producers deploy D-Mannosamine Hydrochloride as a key building block for the modular assembly of heparin and heparan sulfate oligosaccharides. Its use facilitates chemoenzymatic pathway control for sulfation pattern precision, vital for research and regulated drug ingredient production. Industrial protocols require validated process flows and batch record traceability from the raw material specification onward, including tight impurity control. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Nutraceutical Precursor for Functional Food and Beverage FortificationFunctional food manufacturers employ D-Mannosamine Hydrochloride as a precursor in the formulation of targeted prebiotic blends and digestive health supplements. It enhances the formation of beneficial oligosaccharides that support gut microbiota balance. Operations applying this ingredient must comply with international food safety and additive regulations, while adjusting addition levels to regional dosage thresholds and label claims for health foods. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate in Antibiotics and Antiviral Agent SynthesisChemical process manufacturers utilize D-Mannosamine Hydrochloride as an intermediate in the semi-synthetic routes for select aminoglycoside antibiotics and nucleoside analog antivirals. It enters amidation and glycosidic bond-forming reactions within validated multi-step syntheses. Here, control of isomeric purity and residuals at each stage is mandatory for downstream pharmacological acceptability and regulatory batch release. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Active Component in Glycomics and Cell Biology Research ReagentsProducers of biochemical assay kits and research-use-only reagents depend on this material for metabolic glycan-labeling studies and targeted modification of cell-surface carbohydrates. Laboratories require high-purity supply, free from microbial, endotoxin, and heavy metal contamination, supporting cell culture and in vitro workflow reliability. Batch documentation must conform to analytical reference standard requirements for publication and patent submission. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive D-Mannosamine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
The recipe for real reliability in the fine chemicals space comes down to absolute control: every kilogram emerging from our line reflects the detail, consistency, and traceability embedded in our own facilities. D-Mannosamine Hydrochloride (a common model in this class is CAS 26239-55-4) stands out in our suite of amino sugar derivatives. What separates it from raw intermediates isn’t just its purity profile or crystal form; deep experience in upstream raw material handling and advanced conversion reactions keeps batch-to-batch parameters stable, which pharmaceutical and biotech teams depend on for reproducible results.
We design each batch to minimize contamination risk and optimize performance downstream, not only by polishing the process, but by verifying feedstock quality right at our door. Purity levels routinely surpass 99% (HPLC), with water content controlled tightly during final stages and heavy metals managed to well below industry thresholds. Most demand centers on our fine white crystalline powder, which dissolves easily in water, carrying a precise hydrochloride counterion that maintains chemical stability for storage and use.
Measured against its sister compounds, D-Mannosamine Hydrochloride responds better in applications where an amino group at the C-2 position of the sugar ring acts as a site for targeted modification. Research teams exploring glycosylation, carbohydrate-based vaccine candidates, or metabolic pathway mapping reach for this material when standard mannosamine or glucosamine forms don’t offer the necessary reactivity, solubility, or selectivity. Our formulation stays free of common byproducts like glucosamine or trace mineral acids, which can throw off downstream analytics or complicate reference standards.
Glycobiology labs and oligosaccharide synthesis projects push our product for reliability, especially in structural studies of cell-surface interactions, because heterogeneous batches generate conflicting results. Our customers—and our own in-house analytical teams—use NMR, FT-IR, and specific rotation checks to validate identity and absolute configuration every cycle, reducing the burden of re-tests and batch rejection. This isn’t abstract; years of supporting multi-step syntheses demonstrate that early-stage impurity loads propagate, so quality baked in up front saves time and money across a project’s lifetime.
D-Mannosamine Hydrochloride attracts attention beyond classical academic studies. Biopharma companies incorporate it as a precursor for sialic acid analogues— cornerstones of glycoprotein modification work or anti-viral research. Medical diagnostic kit manufacturers rely on its stable and predictable performance when testing for lectin or glycan-binding specificity. Even niche markets like cosmetic research and cell imaging reach for this compound to access rare metabolic pathways or label cell surface carbohydrates.
Since our production line doesn’t depend on generic resellers or trading partners, our product hits the market with a chain-of-custody that withstands scrutiny—from origin extraction through to final QA. This tight linkage keeps our certificates of analysis meaningful, letting clients avoid the detective work of tracing inconsistencies back to opaque supply chains. Our technical team remains on ground to handle escalation on any deviation, troubleshooting not just symptoms, but root causes.
Manufacturing D-Mannosamine Hydrochloride isn’t simply a matter of running a reaction and scooping up the crystals. Process control has to account for humidity, feedstock variability, and even shifts in utilities. Our reactors and purification equipment operate under controlled environmental conditions throughout the year, helping prevent seasonal fluctuations that can cause batch-to-batch drift. Chromatographic analysis and moisture content measurements run at multiple points during finishing and packaging. This lets us intercept issues early, even before the material reaches the final drying phase.
Active collaboration with process engineers and analytical chemists means we respond fast to any deviation. If a nitration step or hydrochloride neutralization shifts yield or color slightly, we adjust parameters and revalidate, rather than blending batches to hide flaws. Documentation supporting every released lot remains detailed and accessible. These realities set manufacturing facilities apart from repackers or distributors, whose control often ends at paperwork, not chemistry.
Other amino sugars—like D-Glucosamine Hydrochloride, N-Acetyl-D-Glucosamine, and simple D-Mannosamine free base—see deployment in dietary or low-grade industrial spaces. But high-purity D-Mannosamine Hydrochloride caters to advanced research. Chemically, the difference traces back to the axial placement of substituents on the sugar ring; even minor configuration changes can drastically alter biological activity and reaction outcomes.
Free bases without the stable hydrochloride salt form tend to degrade faster and take up moisture during shipping, especially outside vacuum-sealed or desiccant-packed regimes. Less robust material may cause variable results in enzymatic assays or synthetic protocols. Since our processes generate consistent particle sizes and minimize dust content, handling during lab-scale or pilot operations produces less loss and contamination, which matters most for costly or short-supply projects.
Direct manufacturing brings unique challenges that influence how end-users experience D-Mannosamine Hydrochloride. Over the years, plant expansion has focused as much on minimizing downtime and cross-contamination risk as on increasing yearly output. Each reactor clean-out, filtration system overhaul, or utility upgrade responds to feedback from production teams and customers who have hit delays due to unplanned outages or maintenance in the past.
Long-term relationships with feedstock producers (including suppliers of D-mannose and related core sugars) let us negotiate early purchasing agreements, which buffer our partners from sudden shortages or cost spikes. This approach also allows for better planning of capacity increases aligned with market trends: surges in demand from the pharmaceutical innovation cycle, not retail or food supplement trends, drive our scheduling.
Clients working with proprietary research often want multi-kilogram quantities delivered on narrow lead times. Rather than pushing those requests through a broker that may pass orders around opaque supply webs, our direct communication and inventory control mean response time drops and transparency rises. Rare projects requiring batch-level modification—alternate crystallization solvents, custom drying cycles, or fractionated particle sizes—get handled in-house, reducing risk of cross-contamination or deviation outside specification.
Real-life manufacturing exposes patterns traders only read about. Years in the plant train a team to spot early warning signs of equipment fatigue, solvent system buildup, or raw material drift. For example, one critical control point in D-Mannosamine Hydrochloride production involves the neutralization and crystallization stage: even small errors in acid/base handling can introduce chloride streams or off-color impurities that elude visual inspection but appear in rigorous chromatographic testing.
These process learnings drive regular investment in better pH meters, moisture analyzers, and analytics software. Our plant team developed internal escalation protocols so if test results edge close to spec boundaries, line workers flag issues directly to quality leads—avoiding the on-paper-only compliance that can creep in with less engaged operators. Real improvements arise from feedback cycles, not checklists alone.
Manufacturing D-Mannosamine Hydrochloride involves hazardous materials, vacuum systems, and temperature-sensitive reactions. We take safety as more than a regulatory requirement—it’s a matter of professional integrity. Continuous training, safety drills, and investment in air handling or chemical containment reduce workplace injuries and environmental emissions. Waste streams undergo treatment onsite, with organic solvents recycled or disposed through certified partners.
Our role as a manufacturer puts the onus on us to minimize environmental impact—not just in material compliance for end-users, but every step from order intake through to final packaging. Monitoring effluent water, reducing byproduct loads, and developing closed-loop handling for solvents remain daily goals. This attitude means when customers inquire about sustainability data, we can back up our claims with documented numbers, not generic assurances.
Projects using D-Mannosamine Hydrochloride tend to evolve as timelines, funding, or downstream targets change. Direct lines to our technical team save end-users hours otherwise spent triangulating answers among brokers. From solubility profiles to shelf-life stability, we share data born from full-lab and pilot-plant investigation, shaped by requests from real projects that needed answers under pressure.
We encourage open dialogue between our chemists and yours: unexpected behavior, analytical anomalies, or process bottlenecks become opportunities to dig deeper into root causes. No sales scripts, just the practical exchange between production experts troubleshooting together. This sharing accelerates not only problem resolution but advances broader know-how across research communities using amino sugar derivatives.
Shifts in research directions keep the landscape for specialty chemicals like D-Mannosamine Hydrochloride in constant motion. As biopharma, diagnostics, or glycobiology research pivots toward new therapeutic strategies, demand for higher purity, lower impurity thresholds, or different salt forms will only grow. Having both R&D chemists and production operators under one roof gives us an edge; pilot batches for new requirements roll out quickly, tweaks to process scale smoothly, and timelines for full-scale manufacturing adapt to customer innovation.
Regulatory scrutiny keeps tightening, especially in globally interconnected supply chains. By being both manufacturer and primary supplier, we keep a single, auditable chain from initial raw sugar processing to validated shipping documentation. This structure lowers risk for downstream partners aiming for regulatory filings or patent applications using our compound as a reference or starting material.
Many providers of D-Mannosamine Hydrochloride source through a patchwork of external vendors, hoping to meet minimum requirements on price and test report. Our commitment puts the science first: full knowledge of the production process, relentless quality monitoring, and investment in plant and personnel set the product apart. Troubles in scaling up enzyme synthesis cascades, or finding impurities not noted in spec sheets, have taught us that only through vertical integration can we correct issues at their source and guarantee what’s in every package.
Whether supporting novel therapeutics or academic studies aiming to map the human glycome, the journey from precursor to final form matters as much as the results. Our ethos puts accountability, technical rigor, and open communication at the core—not just promises, but process and transparency lived out in daily routines. Decades at the bench, in the plant, and inside regulatory audits inform every choice behind each lot of D-Mannosamine Hydrochloride we deliver.